Have a personal or library account? Click to login
Is the allergic reaction to Aspergillus a contraindication for biological therapy in severe asthma? Cover

Is the allergic reaction to Aspergillus a contraindication for biological therapy in severe asthma?

Open Access
|May 2022

References

  1. 1. Global Initiative for Asthma - Global Initiative for Asthma - GINA [Internet]. [cited 2020 Dec 14],2020. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf
  2. 2. Menzella F, Galeone C, Formisano D, Castagnetti C, Ruggiero P, Simonazzi A, et al. Real-life efficacy of omalizumab after 9 years of follow-up. Allergy, Asthma & Immunology Research. 2017;9(4): 368–372.10.4168/aair.2017.9.4.368544695228497924
  3. 3. Loureiro CC, Amaral L, Ferreira JA, Lima R, Pardal C, Fernandes I, et al. Omalizumab for severe asthma beyond allergic asthma. BioMed Research International. 2018. Available from: https://downloads.hindawi.com/journals/bmri/2018/3254094.pdf10.1155/2018/3254094616638330310816
  4. 4. Katsaounou P, Buhl R, Brusselle G, Pfister P, Martinez R, Wahn U, et al. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma. Respiratory Medicine. 2019;150: 51–62. Available from: https://www.resmedjournal.com/article/S0954-6111(19)30039-3/fulltext10.1016/j.rmed.2019.02.00330961951
  5. 5. Hogan C, Denning DW. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Seminars in Respiratory and Critical Care Medicine. 2011;32(6): 682–692.10.1055/s-0031-129571622167396
  6. 6. Farrant J, Brice H, Fowler S, Niven R. Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum. Journal of Asthma. 2016;53(7): 732–735.10.3109/02770903.2016.115407327043956
  7. 7. protocoale-2018-MOf-754Bis_18.pdf [Internet]. [cited 2020 Dec 20]. Available from: http://www.inmas.ro/wp-content/uploads/2018/09/protocoale-2018-MOf-754Bis_18.pdf
  8. 8. Lin CH, Cheng SL. A review of omalizumab for the management of severe asthma. Drug Design, Development and Therapy. 2016;10: 2369–2378.10.2147/DDDT.S112208497063827528798
  9. 9. Froidure A, Mouthuy J, Durham SR, Chanez P, Sibille Y, Pilette C. Asthma phenotypes and IgE responses. European Respiratory Journal. 2016;47(1): 304–319.10.1183/13993003.01824-201426677936
  10. 10. Gauthier M, Ray A, Wenzel SE. Evolving concepts of asthma. American Journal of Respiratory and Critical Care Medicine. 2015;192(6): 660–668.10.1164/rccm.201504-0763PP544729326161792
DOI: https://doi.org/10.2478/pneum-2022-0011 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 55 - 58
Published on: May 28, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2022 Flenches Catalina, Lupusor Eugeniu, Budin Corina, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.